Principal Scientist Vaccine Drug Substance Development Insect Cells & Baculoviruses – Vaccines

Reference No. R2753080

Position Title: Principal Scientist Vaccine Drug Substance Development Insect Cells & Baculoviruses – Vaccines

Department: Global Drug Substance Bioprocess Dev

Location: Toronto, Ontario

We deliver 4.3 billion healthcare solutions to people every year, thanks to the flawless planning and meticulous eye for detail of our Manufacturing & Supply teams. With your talent and ambition, we can do even more to protect people from infectious diseases and bring hope to patients and their families. Your job, as a Principal Scientist Vaccine Drug Substance Development Cell Insect Cells & Baculoviruseswithin our Global Drug Substance Bioprocess Dev, will be to report to the Global Head Vaccine Drug Substance Development and work closely with Unit Heads and Scientists from Vaccine Drug Substance Development group based in Marcy l’étoile and Toronto to accelerate the R&D portfolio.

Vaccines
We are an innovative global healthcare company that helps the world stay ahead of infectious diseases by delivering more than 500 million vaccine doses a year. Across different countries, our talented teams are exploring new technologies to protect people and promote healthy communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.

Main responsibilities:

• Lead implementation of insect cells/baculoviruses “Seeds” and “Upstream” technical activities at Toronto site.

• Ensure mastery and improvement of the Insect cells (SF)/baculoviruses platform : from seeds/banks to upstream stages including molecular engineering of baculoviruses

• Leverage expertise and strong global network to lead definition & realization of CMC platform advancements in particular for the Baculoviruses/Insect cells platform

• This role can balance a 'proximity' to lab activities (including doing some lab work) with some strategic elements

• Drive innovation within Global Vaccine Drug Substance. Development by proposing product, equipment’s and technologies assessment

• Contribute to ensure the successful transfer of processes, techniques, information and systems from Global Vaccine Drug Substance Development to VCDS GMP group.

About you

• PhD or MD/PhD, Engineer with 10+ years of experience developing multi-disciplinary vaccine development programs.

• Experience in drug substance development and industrialization strongly required.

• Understanding of complex R&D landscapes globally, ability to identify cutting-edge technologies and new directions, strong academic and biotech/pharma scientific networks.

• Background and expertises: must have experience and expertise with insect cells/baculoviruses.

• Experience with mammalian cells (e.g. Vero cells), molecular biology, cell line development would be appreciated

• Good oral communication, management, and interpersonal skills.

• Fluent in English.

Why choose us?

• Bring the miracles of science to life alongside a supportive, future-focused team.​

• Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.​

• Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.​

• Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare, prevention and wellness programs and at least 14 weeks’ gender-neutral parental leave.​

Sanofi is an equal opportunity employer committed to diversity and inclusion. Our goal is to attract, develop and retain highly talented employees from diverse backgrounds, allowing us to benefit from a wide variety of experiences and perspectives. We welcome and encourage applications from all qualified applicants.  Accommodations for persons with disabilities required during the recruitment process are available upon request.

#GD-SP #LI-SP​

#LI-Hybrid